AAV-CXCL9 increases tumor infiltration by cytotoxic lymphocytes, sensitizing glioblastoma to anti-PD-1 immune checkpoint blockade in female preclinical tumor...
2 months ago

Press Release, Orbis Research – Worldwide Custom Adeno-Associated Virus (AAV) Services Industry Analysis.
26 minutes ago

This review article provides an overview of adeno-associated virus (AAV)-based microglia targeting approaches, discussing potential prospects for refining...
3 months ago

AAV vectors of nearly all serotypes exhibit effective liver accumulation upon intravenous administration, owing to their inherent affinity for...
8 months ago

Researchers prefer AAV vectors due to their broad tissue tropism, high safety profile, and adaptability in manufacturing procedures.
6 months ago

Adeno-associated Virus Gene Therapy Market Adeno-associated Virus Gene Therapy Market Dublin, June 21, 2024 (GLOBE NEWSWIRE) -- The...
3 months ago

Adeno-associated virus (AAV) has emerged as a pivotal delivery tool in clinical gene therapy owing to its minimal pathogenicity and ability...
6 months ago

Seroprevalence of binding and neutralizing antibodies against 18 adeno-associated virus types in patients with neuromuscular disorders ... High levels of pre-...
1 month ago

Researchers have developed a novel version of a key CRISPR gene-editing protein that shows efficient editing activity and is small enough to...
4 months ago

Recombinant adeno-associated viruses (rAAVs) have emerged as promising gene therapy vectors due to their proven efficacy and safety in...
5 months ago